Literature DB >> 8651099

A specific activity questionnaire to measure the functional capacity of cardiac patients.

S L Rankin1, T G Briffa, A R Morton, J Hung.   

Abstract

Exercise testing is often performed in persons with cardiac disease to measure their functional capacity. Physical activity questionnaires assessing functional capacity have been used a low-cost and convenient alternative to exercise testing, but have not been well validated against measured oxygen consumption in a cardiac population. This study assesses the ability of a simple, 13-item activity questionnaire, known as the Specific Activity Questionnaire (SAQ), to measure functional capacity prospectively in a large sample of cardiac patients. Ninety-seven consecutive cardiac outpatients (85 men and 12 women aged 59 +/- 10 years [mean +/- SD]) completed the SAQ before an elective symptom-limited treadmill test. Subjects returned within 10 days to repeat the treadmill test, following the same protocol, with the additional measurement of peak oxygen consumption, VO2 (ml x kg(-1)min(-1)), using open circuit spirometry. The SAQ score was significantly related to measured peak VO2(r=0.57, p<0.001). Stepwise multiple linear regression analysis found that the addition of patient age, height, and body weight to SAQ score improved the measurement of peak VO2, accounting for 51% of the sample variance (R=0.71, p<0.001). Peak VO2 was obtained from the following regression formula: [formula: see text]. Thus SAQ, a simple 13-item self-administered activity questionnaire, is able to provide a moderately good measure of functional capacity in cardiac patients and may be useful tool in studies of the cardiac population when formal exercise testing is impractical or uneconomical.

Entities:  

Mesh:

Year:  1996        PMID: 8651099     DOI: 10.1016/s0002-9149(97)89157-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  To operate or not on elderly patients with aortic stenosis: the decision and its consequences.

Authors:  B J Bouma; R B van Den Brink; J H van Der Meulen; H A Verheul; E C Cheriex; H P Hamer; E Dekker; K I Lie; J G Tijssen
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

Review 2.  Ramp exercise protocols for clinical and cardiopulmonary exercise testing.

Authors:  J Myers; D Bellin
Journal:  Sports Med       Date:  2000-07       Impact factor: 11.136

3.  Prediction of VO2max with daily step counts for Japanese adult women.

Authors:  Zhen-Bo Cao; Nobuyuki Miyatake; Mitsuru Higuchi; Kazuko Ishikawa-Takata; Motohiko Miyachi; Izumi Tabata
Journal:  Eur J Appl Physiol       Date:  2008-11-05       Impact factor: 3.078

4.  Predicting VO(2max) with an objectively measured physical activity in Japanese men.

Authors:  Zhen-Bo Cao; Nobuyuki Miyatake; Mitsuru Higuchi; Motohiko Miyachi; Izumi Tabata
Journal:  Eur J Appl Physiol       Date:  2010-02-10       Impact factor: 3.078

5.  Correlation of subjective questionnaires with cardiac function as determined by exercise testing in a pediatric population.

Authors:  Rebekah Burns; Inger Olson; Jeffrey Kazmucha; Raymond Balise; Rita Chin; Clifford Chin
Journal:  Pediatr Cardiol       Date:  2010-09-03       Impact factor: 1.655

Review 6.  Patient-reported physical activity questionnaires: a systematic review of content and format.

Authors:  Kate Williams; Anja Frei; Anders Vetsch; Fabienne Dobbels; Milo A Puhan; Katja Rüdell
Journal:  Health Qual Life Outcomes       Date:  2012-03-13       Impact factor: 3.186

Review 7.  A comprehensive systematic review of the development process of 104 patient-reported outcomes (PROs) for physical activity in chronically ill and elderly people.

Authors:  Anja Frei; Kate Williams; Anders Vetsch; Fabienne Dobbels; Laura Jacobs; Katja Rüdell; Milo A Puhan
Journal:  Health Qual Life Outcomes       Date:  2011-12-20       Impact factor: 3.186

8.  The LIPPSMAck POP (Lung Infection Prevention Post Surgery - Major Abdominal - with Pre-Operative Physiotherapy) trial: study protocol for a multi-centre randomised controlled trial.

Authors:  Ianthe Boden; Laura Browning; Elizabeth H Skinner; Julie Reeve; Doa El-Ansary; Iain K Robertson; Linda Denehy
Journal:  Trials       Date:  2015-12-15       Impact factor: 2.279

9.  Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.

Authors:  Hosam Zaky; Hind Elzein; Alawi A Alsheikh-Ali; Arif Al-Mulla
Journal:  Heart Views       Date:  2013-04

10.  Duke Activity Status Index for cardiovascular diseases: validation of the Portuguese translation.

Authors:  Mariana A Coutinho-Myrrha; Rosângela C Dias; Aline A Fernandes; Christiano G Araújo; Mark A Hlatky; Danielle G Pereira; Raquel R Britto
Journal:  Arq Bras Cardiol       Date:  2014-02-17       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.